ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Clinical trials for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PLEURAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to Re-Sensitize tough cancers to chemotherapy
Disease control OngoingThis study is testing a new oral drug called TRC102 (methoxyamine) to see if it can make tumor cells more sensitive to standard chemotherapy drugs. It is for adults with advanced solid tumors or mesothelioma that have spread or stopped responding to usual treatments. The goal is …
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New cancer drug combo enters first human safety tests
Disease control OngoingThis is an early-stage safety study testing a new drug called BAY 1895344 when given with standard chemotherapy drugs (cisplatin with or without gemcitabine). The main goals are to find the safest dose and understand the side effects in people with advanced solid tumors that have…
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC